Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Achillion 205: An Open-Label Phase 2 Proof-of-Concept Study in Patients with C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Treated with ACH-0144471
Langman, Craig
(PD/PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
5/16/19
→
8/31/50
Funding
Achillion Pharmaceuticals, Inc.
View all
View less